Dr. Pavan Devulapally, MD

Dr. Devulapally practices at Total Vascular Care in San Antonio, Texas.

Dr. Devulapally's NPI, 1306085477, was assigned on February 13, 2009. Dr. Devulapally graduated from Gandhi Medical College in 2000. Dr. Devulapally holds Texas license P9550.

Dr. Devulapally's primary practice is Total Vascular Care, at 215 N San Saba, Suite 201, San Antonio, TX 78207. The practice phone is (210) 212-8622.

Dr. Devulapally's primary practice is Total Vascular Care in San Antonio, Texas. Dr. Devulapally is also affiliated with Methodist Hospital. The medical group on file is South Texas Renal Care Group. Dmand AI also links Dr. Devulapally to 4 more hospitals, 3 dialysis centers and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devulapally practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Devulapally's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Devulapally is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Devulapally's licenses on file in 3 states: Texas, Arkansas and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Devulapally treats.

CMS data shows 3,147 Medicare services from Dr. Devulapally across 13 procedure codes in 2024, for 683 Medicare patients. Medicare paid $309,648 for them.

CMS counts 683 Medicare patients who saw Dr. Devulapally in 2026. The largest group is 75 to 84, with 244 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devulapally's median patient age at 70, with 45% women.

In 2026, Dr. Devulapally wrote 2,113 Medicare Part D claims for 348 patients. 81% of them were for generic drugs. CMS names the drug for 1,794 of them, across 45 drugs with 11 or more claims each, at $263,875 in total drug cost. In 2023, CMS named 998 claims across 31 drugs.

Dr. Devulapally accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devulapally as offering telehealth.

Dmand AI links 6 papers to Dr. Devulapally, published from 2021 to 2025. 2025 was the busiest year, with 2. Dr. Devulapally has published most often in Ann Med Surg (Lond). Dr. Devulapally's most frequent co-authors are Syed Anjum Khan, MD, Salim R. Surani, MD and Ramesh Adhikari, MD.

CMS Open Payments shows 95 general payments to Dr. Devulapally from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. OPKO Pharmaceuticals, LLC paid the most, $933.

Dr. Devulapally graduated from Gandhi Medical College in 2000.

Dr. Devulapally is in network with 24 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.